 |
|
0 new discussion posts (76 published)
Sign in to view your progression
|
The International Course on the Clinical Management of Drug-Resistant Tuberculosis is an online training course, consisting of on-demand videos, quizzes, discussions and practical exercises, aiming to strengthen participants’ capacity in the clinical and programmatic management of drug-resistant tuberculosis.
For the 2023 edition of the course, completion of the online materials is optional. There is an in-person session from the 4th to the 8th December 2023 in Taipei, Taiwan. The in-person session is being organised in partnership with Wan Fang Hospital Taipei Medical University, Taiwan Anti-TB Association and Taiwan CDC.
Module 1
- Principles of TB care and prevention
- TB: The organism and the host
- Basic concepts of drug-resistance in TB
- Global epidemiology of drug-resistant TB and contributing factors
- Clinical and radiographic manifestations of TB and drug-resistant TB
- Conventional anti-TB drug susceptibility testing
- Rapid diagnosis of drug-resistant TB: Xpert
- Rapid diagnosis of drug-resistant TB: Line probe assay
Module 2
- Case finding of drug-resistant TB
- Treatment of new and previously treated TB, isoniazis resistant TB
- Treatment of rifampicin-resistant TB: long regimen and fluoroquinolone
- Bedaquiline, linezolid, Clofazimine
- Delamanid, Pretomanid, Imipenem/Meropenem
- Short course chemotherapy for MDR-TB
- HIV and MDR-TB: clinical manifestations and diagnosis
- Management of DR-TB among people living with HIV
Module 3
- Active tuberculosis drug safety monitoring and management (aDSM)
- Management of adverse drug reactions
- Management of DR-TB in patients with liver disease, renal insufficiency and pregnancy
- MDR-TB in children and management of contact of DR-TB
- Surgical intervention in the management of MDR- and XDR-TB
- Care and support for patients with MDR/RR-TB
- Infection control - minimal requirements
- Management of drug-resistant TB in the era of COVID-19
At the end of this course, participants will be able to:
- Describe the current global epidemiological situation of drug-resistant tuberculosis
- Review the different approaches for the detection and diagnosis of drug-resistant tuberculosis
- Address the basics of ideal treatment, according to different patterns of drug-resistance
- Review second-line medicines and new drugs
- Discuss common problems and possible solutions for programmatic management of drug-resistant tuberculosis
This course is designed for clinicians, who are responsible for diagnosis and treatment of drug-resistant tuberculosis, staff of national tuberculosis programmes and technical partners, working in tuberculosis care and prevention, in low- and middle-income countries, especially in settings where programmatic management of drug-resistant tuberculosis (PMDT) had been or is going to be implemented.
The completion of the online materials is optional for the 2023 edition of this course.
The in-person session will take place from the 4th to the 8th December 2023 in Taipei, Taiwan.
The in-person session is being organised in partnership with Wan Fang Hospital Taipei Medical University, Taiwan Anti-TB Association and Taiwan CDC.
|
Pre-assessment
|
|
|
Week 1 | Part 1
|
|
|
Week 1 | Part 2
|
|
|
Week 2 | Part 1
|
|
|
Week 2 | Part 2
|
|
|
Week 3 | Part 1
|
|
|
Week 3 | Part 2
|
|
|
Assessment and Evaluation
|
|